Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation.
about
P1343
Altered Mitochondrial Signalling and Metabolism in Cancer.Increased lanosterol turnover: a metabolic burden for daunorubicin-resistant leukemia cells.Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins.
P2860
Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Establishment and characteriza ...... mevalonate pathway activation.
@en
type
label
Establishment and characteriza ...... mevalonate pathway activation.
@en
prefLabel
Establishment and characteriza ...... mevalonate pathway activation.
@en
P2093
P2860
P1433
P1476
Establishment and characteriza ...... mevalonate pathway activation
@en
P2093
Annemarie Greife
Christine Steinhoff
Jiri Hatina
Jitka Tukova
P2860
P2888
P304
P356
10.1007/S13277-014-2959-9
P4510
P577
2015-01-08T00:00:00Z
P5875
P6179
1003030208